RXRX vs VNO · rev $14.1M vs rev $921.3M
Recursion Pharmaceuticals Inc (RXRX) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
VNO (VNO) common stock.
Latest reported RXRX revenue for 2026-06-30 was $14.1M. Net income was -$248.5M. RXRX currently screens at market cap $1.75B.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
RXRX currently screens at market cap $1.75B. VNO currently screens at market cap $0.
Not investment advice. Open the RXRX and VNO stock pages for the full models.
Not investment advice.